UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

Clinical pharmacology and therapeutics, 2009-07, Vol.86 (1), p.97-100

2009

Volltextzugriff (PDF)

Cancer biomarkers: selecting the right drug for the right patient

Nature reviews. Drug discovery, 2012-03, Vol.11 (3), p.201-214

2012

Volltextzugriff (PDF)

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Clinical cancer research, 2005-04, Vol.11 (8), p.2785-2808

2005

Volltextzugriff (PDF)

Considerations in the development of circulating tumor cell technology for clinical use

Journal of translational medicine, 2012-07, Vol.10 (1), p.138-138, Article 138

2012

Volltextzugriff (PDF)

Lessons Learned: Transfer of the High‐Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform

Clinical pharmacology and therapeutics, 2017-11, Vol.102 (5), p.777-785

2017

Volltextzugriff (PDF)

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Clinical cancer research, 2005-11, Vol.11 (22), p.7967-7985

2005

Volltextzugriff (PDF)

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development

Clinical cancer research, 2004-06, Vol.10 (11), p.3885-3896

2004

Volltextzugriff (PDF)

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

JNCI : Journal of the National Cancer Institute, 2009-11, Vol.101 (21), p.1453-1463

2009

Volltextzugriff (PDF)

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Clinical cancer research, 2015-04, Vol.21 (7), p.1514-1524

2015

Volltextzugriff (PDF)

Progress in Cancer chemoprevention : Development of diet-derived chemopreventive agents

The Journal of nutrition, 2000-02, Vol.130 (2), p.467S-471S

2000

Volltextzugriff (PDF)

Lipoxygenase Inhibitors as Potential Cancer Chemopreventives

Cancer epidemiology, biomarkers & prevention, 1999-05, Vol.8 (5), p.467-483

1999

Volltextzugriff (PDF)

Retinoids in chemoprevention and differentiation therapy

Carcinogenesis (New York), 2000-07, Vol.21 (7), p.1271-1279

2000

Volltextzugriff (PDF)

Imaging and Oncologic Drug Development

Journal of clinical oncology, 2006-07, Vol.24 (20), p.3261-3273

2006

Volltextzugriff (PDF)

Is Inducible Nitric Oxide Synthase a Target for Chemoprevention?

Molecular cancer therapeutics, 2003-08, Vol.2 (8), p.815

2003

Volltextzugriff (PDF)

Biomarker development in the context of urologic cancers

Urologic oncology, 2015-06, Vol.33 (6), p.295-301

2015

Volltextzugriff (PDF)

New science-based endpoints to accelerate oncology drug development

European journal of cancer (1990), 2005-03, Vol.41 (4), p.491-501

2005

Volltextzugriff (PDF)

The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention

Cancer epidemiology, biomarkers & prevention, 2007-07, Vol.16 (7), p.1330-1340

2007

Volltextzugriff (PDF)

Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays

Carcinogenesis (New York), 2000-01, Vol.21 (1), p.63-67

2000

Volltextzugriff (PDF)

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

Clinical cancer research, 2004-06, Vol.10 (11), p.3919-3926

2004

Volltextzugriff (PDF)

Challenges to Using Big Data in Cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8), p.1175-1182

2023

Volltextzugriff (PDF)

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer

Clinical cancer research, 2014-03, Vol.20 (6), p.1428-1444

2014

Volltextzugriff (PDF)

Chemopreventive drug development: perspectives and progress

Cancer epidemiology, biomarkers & prevention, 1994-01, Vol.3 (1), p.85

1994

Volltextzugriff (PDF)

Chemoprevention of Prostate Cancer: Concepts and Strategies

European urology, 1999, Vol.35 (5-6), p.342-350

1999

Volltextzugriff (PDF)

Case Studies for Overcoming Challenges in Using Big Data in Cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8), p.1183-1190

2023

Volltextzugriff (PDF)

1 – 25 von 583

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(526)
Mit Volltextzugriff
(473)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(341)
Life Sciences & Biomedicine
(242)
Humans
(211)
Biological And Medical Sciences
(144)
Male
(109)
Female
(106)
Medical Sciences
(105)
Physical Sciences
(87)
Social Sciences
(80)
Chemistry
(62)
Psychology
(62)
Animals
(60)
Oncology
(48)
Psychology, Developmental
(48)
Psychology. Psychoanalysis. Psychiatry
(45)
Fundamental And Applied Biological Sciences. Psychology
(42)
Child
(41)
Biochemistry & Molecular Biology
(39)
Child, Preschool
(37)
Psychopathology. Psychiatry
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy

Cancer biomarkers: selecting the right drug for the right patient

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Considerations in the development of circulating tumor cell technology for clinical use

Lessons Learned: Transfer of the High‐Definition Circulating Tumor Cell Assay Platform to Development as a Commercialized Clinical Assay Platform

The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development

A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Progress in Cancer chemoprevention : Development of diet-derived chemopreventive agents

Lipoxygenase Inhibitors as Potential Cancer Chemopreventives

Retinoids in chemoprevention and differentiation therapy

Imaging and Oncologic Drug Development

Is Inducible Nitric Oxide Synthase a Target for Chemoprevention?

Biomarker development in the context of urologic cancers

New science-based endpoints to accelerate oncology drug development

The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention

Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

Challenges to Using Big Data in Cancer

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer

Chemopreventive drug development: perspectives and progress

Chemoprevention of Prostate Cancer: Concepts and Strategies

Case Studies for Overcoming Challenges in Using Big Data in Cancer

Aktive Filter

Suchergebnisse filtern